ka lapaʻau ʻana i ka maʻi maʻi maʻi maʻi renal cell prognosis

Hoʻomaʻamaʻa ʻana i ka maʻi maʻi maʻi maʻi Renal: Prognosis a me nā ʻano o kēia manawa. Hāʻawi kēia ʻatikala i kahi hiʻohiʻona o nā ala lapaʻau o kēia manawa no RCC a e ʻimi i nā kumu e hoʻopiʻi nei i ka wānana, me ka manaʻo e hāʻawi i kahi ʻike maopopo no ka poʻe e ʻimi nei i ka ʻike no kēia maʻi paʻakikī. E nānā mākou i nā pae like ʻole, nā koho lapaʻau, a me ka ʻike no nā poʻe i ʻike ʻia me RCC.

Ka hoʻomaopopo ʻana i ka maʻi maʻi maʻi maʻi Renal

He aha ka Renal Cell Carcinoma?

ʻO ka maʻi maʻi maʻi maʻi renal (ka lapaʻau ʻana i ka maʻi maʻi maʻi maʻi renal cell prognosis) he maʻi maʻi maʻi i puka mai ma ka ʻili o nā ʻōpū o ka puʻupaʻa. ʻO kēia mau paipu liʻiliʻi e kānana i nā mea ʻōpala mai ke koko. ʻAʻole ʻike ʻia ke kumu maoli o ka RCC, akā ua ʻike ʻia kekahi mau mea pilikia, e like me ka puhi ʻana, ka momona, ke koko kiʻekiʻe, a me ka mōʻaukala ʻohana o ka maʻi.

Hoʻopaʻa i ka maʻi maʻi maʻi maʻi maʻi maʻi

ʻO ka pae o RCC i ka maʻi maʻi he mea koʻikoʻi koʻikoʻi o ka prognosis. Nā ʻōnaehana hoʻonohonoho, e like me ka ʻōnaehana TNM (Tumor, Node, Metastasis), kōkua i nā kauka e loiloi i ka nui o ka laha ʻana o ka maʻi kanesa. Aia nā pae mai I (localized) a i IV (metastatic), me nā pae kiʻekiʻe e hōʻike ana i kahi prognosis ʻilihune. He mea koʻikoʻi ka hoʻonohonoho pololei ʻana no ka hoʻoholo ʻana i ka hoʻolālā lapaʻau kūpono loa.

Nā koho lapaʻau no ka maʻi maʻi maʻi maʻi maʻi

Hoʻopili ʻia ke ala lapaʻau no RCC i kēlā me kēia maʻi a hilinaʻi nui i ka pae o ka maʻi kanesa, ke olakino holoʻokoʻa o ka mea maʻi, a me nā mea pili ʻē aʻe. Aia nā koho lapaʻau:

ʻO ka ʻoki ʻana

No ka RCC kūloko, ʻo ka ʻoki ʻana (e like me ka nephrectomy ʻāpana a i ʻole ka nephrectomy radical) ʻo ia ka mea maʻamau ke koho mua. ʻO ka wehe ʻana i ka maʻi maʻi maʻi e manaʻo e hoʻōla piha, ʻoi aku ka maikaʻi ma nā pae mua. ʻO ka nui o ka ʻoki ʻana e pili ana i ka wahi a me ka nui o ka tumor.

ʻO ka Lapaʻau Kūlohelohe

Hoʻolālā ʻia nā lāʻau lapaʻau i hoʻopaʻa ʻia no ka hoʻouka ʻana i nā maʻi maʻi maʻi me ka ʻole o ka hōʻino ʻana i nā cell olakino. ʻO kekahi mau lāʻau lapaʻau i manaʻo ʻia, e like me sunitinib, pazopanib, a me axitinib, ua hōʻike i ka maikaʻi i ka mālama ʻana i ka RCC kiʻekiʻe (pae III a me IV). Hoʻopaʻa pinepine kēia mau lāʻau i nā protein kikoʻī i pili i ka ulu ʻana o ke kanesa.

Immunotherapy

Hoʻohana ka Immunotherapy i ka mana o ka ʻōnaehana pale o ke kino e hakakā ai i ka maʻi kanesa. ʻO nā lāʻau lapaʻau e like me ka nivolumab a me ka ipilimumab e hoʻoulu i ka ʻōnaehana pale e ʻike a luku i nā maʻi kanesa. Ua hoʻololi ka Immunotherapy i ka mālama ʻana i ka RCC kiʻekiʻe a hiki ke alakaʻi i nā pane lōʻihi.

Kemoterapi

ʻOiai ʻaʻole i hoʻohana pinepine ʻia ka chemotherapy ma ke ʻano he lāʻau lapaʻau mua no RCC i hoʻohālikelike ʻia i ka lāʻau lapaʻau a me ka immunotherapy, hiki ke pāʻani i kahi hana ma nā kūlana kikoʻī, e like me ka mālama ʻana i ka maʻi metastatic a i ʻole ma hope o ke kaʻina e hōʻemi i ka pilikia o ka hoʻi hou ʻana.

Nā mea e hoʻopili ai i ka wānana no ka maʻi maʻi maʻi maʻi maʻi

Nui nā kumu i ka wānana o RCC, e like me:

Kumukumu	Ka hopena ma ka Prognosis
Pae ma ka hōʻoia	Hoʻopili ʻia nā pae kiʻekiʻe me kahi prognosis ʻilihune.
Papa kūʻokoʻa	ʻOi aku ka maikaʻi o ka wānana ʻana i nā maʻi ʻokoʻa kiʻekiʻe (e hōʻike ana i ka ulu ʻoi aku ka ikaika.
Loaʻa i ka metastasis	ʻO ka maʻi metastatic ka mea e hōʻemi nui ai i nā helu ola.
ʻO ke olakino holoʻokoʻa o ka maʻi	Hiki i nā kūlana lapa'au mua ke ho'ololi i ka ho'omanawanui a me ka hopena.

Papa 1: Nā mea e pili ana i ka prognosis o Renal Cell Carcinoma

Ka nānā ʻana a me ka mālama ʻana

Ma hope o ka mālama ʻana no RCC, he mea koʻikoʻi nā koho maʻamau no ka nānā ʻana no ka hoʻi hou ʻana a me ka mālama ʻana i nā hopena ʻaoʻao. Hoʻokomo pinepine ʻia kēia mau koho i nā hoʻokolohua kino, nā hoʻāʻo koko, a me nā noiʻi kiʻi (e laʻa, CT scans). He mea nui ka ʻike mua ʻana o ka hoʻi hou ʻana no ka hoʻokō koke ʻana a me ka hoʻomaikaʻi ʻana i nā hopena.

Ka hopena

ʻO ka ka lapaʻau ʻana i ka maʻi maʻi maʻi maʻi renal cell prognosis ʻokoʻa nui ma muli o nā kumu he nui, ʻo ka pae mua o ka maʻi kanesa ma ka maʻi maʻi. He mea koʻikoʻi ka ʻike mua ʻana a me ka mālama koke ʻana no ka hoʻomaikaʻi ʻana i nā hopena. ʻO nā holomua i nā lāʻau lapaʻau i hoʻopaʻa ʻia a me nā immunotherapies ua hoʻomaikaʻi maikaʻi i ka prognosis no nā poʻe he nui me RCC. No ka 'ike hou aku a me ka mālama 'ana i ka ma'i 'a'ai, e 'olu'olu e kipa Shandong Baofa Cancer Research Institute. E hoʻomanaʻo e kūkākūkā me kāu mea mālama ola no ka ʻōlelo aʻo pilikino a me ka hoʻolālā lapaʻau.

'Ōlelo Aʻo: No ka hoʻonaʻauao wale nō kēia ʻike a ʻaʻole pono e manaʻo ʻia he ʻōlelo aʻoaʻo olakino. E kūkākūkā mau me kekahi ʻoihana mālama ola kūpono no ka hōʻoia ʻana a me ka mālama ʻana i kekahi maʻi olakino.